47 model-driven-development "Integreat Norwegian Centre for Knowledge driven Machine Learning" Fellowship positions at Northeastern University
Sort by
Refine Your Search
-
and Twitter/X. Responsibilities Early Development Fellowship Description: Early Development comprises Clinical Pharmacology (CP), Modeling & Simulations (M&S), and Early Development Medical Directors
-
, and support the strategic dissemination of data that advances patient care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
About the Opportunity About the Opportunity The Northeastern University Pharmaceutical Industry Fellowship Program is a two-year experiential program designed to prepare Pharm.D. graduates
-
have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
clinical knowledge to enable efficient and effective drug development. Clinical Scientists contribute throughout the development cycle from Phase 1 to IND submission. They are data-driven, scientific leaders
-
lightweighting, hypersonic systems, and naval shipbuilding. The Fellow will contribute to ongoing research programs by developing experimental methodologies, computational models, and performing hands
-
collaborates with health networks and payers while rethinking pricing models for innovative treatments in development. The organization is dedicated to transforming genetic understanding into genetic medicine